本文章的学术内容和语言评估
本文章的CrossCheck查重和Google搜索
本文章的学术规范
本文章的引用
本文章的通讯作者
本文章的研究领域
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
- 本文章浏览次数 (6233)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 27, 2023 (publication date) through Sep 26, 2024
本文章的被引频次
本文章的期刊信息
出版物名称
World Journal of Hepatology
ISSN
1948-5182
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ng JJJ, Loo WM, Siah KTH. Associations between irritable bowel syndrome and non-alcoholic fatty liver disease: A systematic review. World J Hepatol 2023; 15(7): 925-938 [PMID: 37547029 DOI: 10.4254/wjh.v15.i7.925] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v15/i7/925.htm |
| 编号 | Citing Articles |
| 1 |
Mihaela Rotaru, Ana-Maria Singeap, Alin Ciobica, Laura Huiban, Carol Stanciu, Laura Romila, Vasile Burlui, Ioannis Mavroudis, Anca Trifan. Oral Health and “Modern” Digestive Diseases: Pathophysiologic and Etiologic Factors. Biomedicines 2024; 12(8): 1854 doi: 10.3390/biomedicines12081854
|
| 2 |
Md. Musab Khalil, Sirajam Munira, Md. Mahbubul Alam, Al Mahmood Appolo, Musatafa Md. Abu Sayeed, Atikul Islam, Narwana Khaleque, Mohammad Faisal, Arifa Tasnim, Ruma Najnin, Mahmudur Rahman, Enamul Karim, Md. Golam Kibria. Prevalence of Nonalcoholic Fatty Liver Disease [NAFLD] and Metabolic dysfunction associated Fatty Liver Disease [MAFLD] in patients with Irritable Bowel Syndrome [IBS]. SN Comprehensive Clinical Medicine 2024; 6(1) doi: 10.1007/s42399-024-01675-5
|
| 3 |
Federica Fogacci, Marina Giovannini, Valentina Di Micoli, Elisa Grandi, Claudio Borghi, Arrigo Francesco Giuseppe Cicero. Effect of Supplementation of a Butyrate-Based Formula in Individuals with Liver Steatosis and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Nutrients 2024; 16(15): 2454 doi: 10.3390/nu16152454
|